Loading...
Cholinesterase inhibitors as Alzheimer's therapeutics
Alzheimer's disease (AD) is one of the most common forms of dementia. AD is a chronic syndrome of the central nervous system that causes a decline in cognitive function and language ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed...
Saved in:
| Published in: | Mol Med Rep |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6625431/ https://ncbi.nlm.nih.gov/pubmed/31257471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|